InvestorsHub Logo
icon url

MFK

05/25/10 12:17 PM

#88511 RE: banyon #88508

Banyon, I truly think that the move to OTC: BB will be the one we should be looking for the most. Investors are interested in transparancy and by moving to OTC: BB Behl will be exposed to the bigger market and consequently bigger investors. We need bigger investors here to create better volume and with volume almost every thing will be solved. This is a great company and the idea is not in question, it is the exposure to the bigger market that is the problem. I think.
icon url

bdubble

05/25/10 12:27 PM

#88515 RE: banyon #88508

Im not sure you had the right strain of mold. Try the penicillin G (benzylpenicillin) strand, it also has three stages of biosynthesis and the necessary aminos etc. (which I doubt the bread contained the proper), sounds like you you only attempted one stage of underthebedysis. Funny that you brought that up, it is like algae in a way, that they both require certain conditions, certain amino's etc. to be correct. I am confident that BEHL has figured out how to "grow algae", I think at this point it has come to how quickly and cost efficient they can do this.